PsychoGenics Inc. awarded a $3 million SBIR grant to employ its AI-enabled platforms for finding treatments for rare disorders.
PRIVATEAug 28, 2024
Amount Raised
$3 Million
Round Type
Seed
ParamusBiotechnology
Description
PsychoGenics has received a Fast Track Small Business Innovation Research grant worth up to $3 million, which will support the use of its AI-enabled EEG platform to identify applications for existing drugs targeting rare diseases. This initiative aims to provide rapid treatment options for the approximately 10,000 rare diseases affecting millions worldwide.
Who to call at PsychoGenics, and when
A new round usually means PsychoGenics is about to hire and buy. The teams that reach out first get the meeting.
An alert the day PsychoGenics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at PsychoGenics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at PsychoGenics. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
PsychoGenics
Location
Paramus, New Jersey, United States
About
PsychoGenics is a leading biotechnology company dedicated to revolutionizing drug discovery through AI-enabled platforms. They have pioneered the translation of rodent behavioral and physiological responses into high-throughput phenotyping. Their platforms have facilitated partnerships with major pharmaceutical companies, leading to several novel compounds in advanced development. PsychoGenics also provides mouse models for research in various neurological and psychiatric conditions.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment PsychoGenics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
ParamusBiotechnology